How Do We Treat Early-Stage NSCLC in 2025?
Read time: 3 minutes. Roughly 20% of lung cancer is diagnosed as early-stage disease, and researchers have been working to improve treatment options for these patients—with
Diagnosis & Treatment Blogs
-
-
Treating Small Cell Lung Cancer: 2025 and Beyond
Read time: 2 minutes. Researchers have been trying to find new ways to treat small cell lung cancer (SCLC) for a long time. Those efforts are starting to pay off in big ways. Join -
Real-World Examples of Patient Involvement in Designing Clinical Trials
Read time: 2 minutes. Here we present the final video in our three-part series about how patients and researchers can work together to develop clinical trials. In the video below -
Developing Clinical Trials that Account for the Realities of Patient Life
Read time: 2 minutes. We are pleased to continue our three-part series about how patients and researchers can work together to develop clinical trials. In this second video -
The 5 Most Popular Lung Cancer Blogs From 2024
Read time: 3 minutes. Throughout 2024 we published blogs sharing scientific meeting recaps, educational content, personal stories, treatment news, and so much more. Below are the -
Bringing the Underserved LGBTQIA2S+ Community into the Lung Cancer Spotlight
Updated: June 10, 2025 Editor's Note: This important research project is already yielding many tangible results, including being published in the Annals of the American Thoracic -
Brain Mets Basics for NSCLC: What Are Brain Metastases and How Do We Treat Them?
Read time: 2 minutes. Brain metastases (also called brain mets) develop when cancer from somewhere else in the body spreads to the brain. Over time, tumors can become metastatic -
Meet the College Students Raising Awareness for Lung Cancer and Lung Cancer Screening
Read time: 4 minutes. Editor's Note: This article has been updated for 2025 as LUNGevity and ALCSI continue their partnership for Lung Cancer Awareness Month. Anyone with lungs can -
How Do Drugs Get Approved (and Fast-Tracked) by the FDA?
Read time: 5 minutes. This is Part 3 in our series on how drugs get approved to treat lung cancer. Part 1: Understanding Clinical Trials - Why Are They Important for Drug -
FDA Approves New Immunotherapy Option for Early-Stage NSCLC
On August 15, 2024, the US Food and Drug Administration (FDA) approved a new treatment regimen for people newly diagnosed with early-stage, resectable (able to be removed by -
New Chemotherapy-Free Treatment Combination Approved for EGFR+ Lung Cancer
On August 19, 2024, the US Food and Drug Administration (FDA) approved a new treatment option for people newly diagnosed with locally advanced or metastatic non-small cell lung -
How We Define Success for a Clinical Trial
Read time: 6 minutes. This is Part 2 of 3 in our series on how drugs get approved to treat lung cancer. Make sure to read Part 1 on the phases of clinical trials and why they are